We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Mesoblast Limited stands tenth on our ...

Durvalumab's breakthrough therapy designation offers hope for improved outcomes in early-stage gastric and GEJ cancers, potentially transforming treatment strategies.

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 11.2% in pre-market trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

With the introduction of genAI tool Elsa at the FDA in June, the technology is playing a greater role in the medical device review process.

Investing.com -- Stereotaxis (NYSE: STXS) stock surged 12% after the company received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its MAGiC Sweep catheter, the world’s first ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.